<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1561-3194</journal-id>
<journal-title><![CDATA[Revista de Ciencias Médicas de Pinar del Río]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Ciencias Médicas]]></abbrev-journal-title>
<issn>1561-3194</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1561-31942023000500018</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Caracterización del Síndrome metabólico en diabéticos tipo 2 atendidos en el Centro Provincial de Pinar del Río]]></article-title>
<article-title xml:lang="en"><![CDATA[Characterisation of the metabolic syndrome in type 2 diabetics treated at the Provincial Centre of Pinar del Río]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rosa]]></surname>
<given-names><![CDATA[Yazuina Fuentes-De La]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz-Cabrera]]></surname>
<given-names><![CDATA[José Caridad]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz-Calzada]]></surname>
<given-names><![CDATA[Marvelia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez-Sardiñas]]></surname>
<given-names><![CDATA[Lazara Maidelys]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez-Alvarez]]></surname>
<given-names><![CDATA[Yohanka]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Pinar del Río. Facultad de Ciencias Médicas Dr. Ernesto Guevara de la Serna ]]></institution>
<addr-line><![CDATA[Pinar del Río ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Ciencias Médicas de Pinar del Río. Policlínico Universitario Luis Augusto Turcios Lima. ]]></institution>
<addr-line><![CDATA[Pinar del Río, ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2023</year>
</pub-date>
<volume>27</volume>
<numero>4</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1561-31942023000500018&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1561-31942023000500018&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1561-31942023000500018&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: el Síndrome Metabólico es un problema grave, incrementándose su incidencia, asociado a la Diabetes Mellitus.  Objetivo: caracterizar el Síndrome Metabólico en pacientes diabéticos tipo 2 en el Centro de Atención al Diabético de Pinar Del Rio en el período enero -septiembre 2020.  Métodos:  se realizó un estudio observacional, descriptivo, corte transversal en el Centro de Atención al Diabético de Pinar Del Rio, enero-septiembre 2021. El universo estuvo conformado por 88 pacientes con Diabetes Mellitus tipo 2 y la muestra de manera intencional por 44. La información extraída de las historias clínicas fue procesada empleando el programa SPSS versión 22, calculando frecuencias y la prueba Ji cuadrado (X2),significativa si p&lt;0.05. Se diagnosticó Síndrome Metabólico utilizando criterios de la NCEP-ATP III.  Resultados: el Síndrome Metabólico se diagnosticó en el 70,45 %, predominando el sexo femenino (67,74 %) y edades de 60 a 69 años, presentó preponderancia entre pacientes diabéticos tipo 2, predominando en mujeres posmenopáusicas. La Hipertensión Arterial, la obesidad abdominal y triglicéridos elevados fueron los componentes más frecuentes y el ácido úrico y la Aspartato Amino Transferasa, los parámetros bioquímicos más elevados.  Conclusiones:  el Síndrome metabólico aparece frecuentemente en pacientes con Diabetes mellitus tipo 2 elevando parámetros como ácido úrico y ASAT.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Metabolic Syndrome is a serious problem, increasing its incidence, associated with Diabetes Mellitus.  Objective:  To characterise the Metabolic Syndrome in type 2 diabetic patients in the Diabetic Care Centre of Pinar Del Rio in the period January-September 2020.  Methods:  An observational, descriptive, cross-sectional, descriptive study was carried out in the Diabetic Care Centre of Pinar Del Rio, January-September 2021. The universe consisted of 88 patients with type 2 diabetes mellitus and the sample consisted of 44. The information extracted from the medical records was processed using SPSS version 22, calculating frequencies and the chi-squared test (X2), which was significant if p&lt;0.05. Metabolic syndrome was diagnosed using NCEP-ATP III criteria.  Results:  Metabolic syndrome was diagnosed in 70,45 % of patients, predominantly female (67,74 %) and aged between 60 and 69 years, with a preponderance of type 2 diabetic patients, predominantly postmenopausal women. Arterial Hypertension, abdominal obesity and elevated triglycerides were the most frequent components and uric acid and Aspartate Amino Transferase, the highest biochemical parameters.  Conclusions:  Metabolic syndrome appears frequently in patients with type 2 diabetes mellitus with elevated parameters such as uric acid and ASAT.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[SÍNDROME METABÓLICO]]></kwd>
<kwd lng="es"><![CDATA[DIABETES MELLITUS TIPO 2]]></kwd>
<kwd lng="es"><![CDATA[RESISTENCIA A LA INSULINA.]]></kwd>
<kwd lng="en"><![CDATA[METABOLIC SYNDROME]]></kwd>
<kwd lng="en"><![CDATA[DIABETES MELLITUS, TYPE 2]]></kwd>
<kwd lng="en"><![CDATA[INSULIN RESISTANCE.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rufín-Gómez]]></surname>
<given-names><![CDATA[LÁ]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Morejón]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rufín-Bergado]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez-Martínez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico, un factor de riesgo en pacientes de COVID-19.]]></article-title>
<source><![CDATA[Rev. Med. Electrón]]></source>
<year>2022</year>
<volume>44</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>142-54</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda Guillot]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Pimienta Concepción]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Microbiota intestinal y diabetes.]]></article-title>
<source><![CDATA[Universidad y Sociedad]]></source>
<year>2022</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>158-63</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trujillo-Hernández]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Trujillo-Magallón]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Trujillo-Magallón]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Brizuela-Araujo]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[García-Medina]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[González-Jiménez M]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frecuencia del síndrome metabólico y factores de riesgo en adultos con y sin diabetes mellitus e hipertensión arterial.]]></article-title>
<source><![CDATA[Rev. salud pública]]></source>
<year>2017</year>
<volume>19</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>609-616.</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodrigues Ticiana]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Canani Luis]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Gross]]></surname>
<given-names><![CDATA[JL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólica, resistência à ação da insulina e doença cardiovascular no diabete melito tipo 1.]]></article-title>
<source><![CDATA[Arquivos Brasileiros de Cardiologia]]></source>
<year>2010</year>
<volume>94</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>134-139.</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cubas]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Arnold]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de tres metodologías para la predicción del riesgo de alteraciones del metabolismo de la glucosa en sujetos con sobrepeso y obesidad.]]></article-title>
<source><![CDATA[Rev Cub de Endocrinol]]></source>
<year>2017</year>
<volume>28</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kabadi]]></surname>
<given-names><![CDATA[UM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Major Pathophysiology in Prediabetes and Type 2 Diabetes: Decreased Insulin in Lean and Insulin Resistance in Obese.]]></article-title>
<source><![CDATA[Journal of the Endocrine Society]]></source>
<year>2017</year>
<volume>1</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>742-750.</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coz Calumani]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cuba Sancho]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intervenciones para prevenir el síndrome metabólico en adolescentes.]]></article-title>
<source><![CDATA[Rev Cubana Enfermer]]></source>
<year>2021</year>
<volume>37</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vera-Ponce]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Talavera]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Malca]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[De-La-Cruz-Vargas]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Combinaciones de síndrome metabólico y riesgo de diabetes mellitus.]]></article-title>
<source><![CDATA[Revista Cubana de Medicina Militar]]></source>
<year>2022</year>
<volume>51</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<source><![CDATA[Ministerio de Salud Pública. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2018]]></source>
<year>2019</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[MINSAP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pimazoni Netto]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[Conducta Terapéutica no Diabetes tipo 2: Algoritmo SBD]]></source>
<year>2019</year>
<publisher-loc><![CDATA[São Paulo ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association.</collab>
<article-title xml:lang=""><![CDATA[Standards of medical care in diabetes 2014]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2014</year>
<volume>37</volume>
<numero>^sSuppl 1</numero>
<issue>^sSuppl 1</issue>
<supplement>Suppl 1</supplement>
<page-range>S14&#8210;80</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morejón Giraldoni]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Benet Rodríguez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez de la Cotera]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[García Torres]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Salas Rodríguez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ordúñez García]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Síndrome metabólico en un área de salud de Cienfuegos. Segunda medición de CARMEN.]]></article-title>
<source><![CDATA[Rev Finlay]]></source>
<year>2011</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>6-16.</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Araujo Duran]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización del síndrome metabólico en pacientes de la provincia de Santiago de Cuba, año 2010.]]></article-title>
<source><![CDATA[Rev Latinoamer Patol Clin]]></source>
<year>2013</year>
<volume>60</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>96-101.</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez Torres]]></surname>
<given-names><![CDATA[FD]]></given-names>
</name>
<name>
<surname><![CDATA[González Lemoine]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Legrá Sevila]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pereña Haber]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[López Herrera]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia del síndrome metabólico en población de 15 a 74 años del municipio Guantánamo.]]></article-title>
<source><![CDATA[Rev Inf Cient]]></source>
<year>2017</year>
<volume>96</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>454-465.</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fonte Medina]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sanabría Negrín]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Bencomo Fonte]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Fonte Medina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Negreria]]></surname>
<given-names><![CDATA[IL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo asociados y prevalencia de síndrome metabólico en la tercera edad.]]></article-title>
<source><![CDATA[Rev. cienc. méd. Pinar Río]]></source>
<year>2014</year>
<volume>18</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>963-973.</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="book">
<source><![CDATA[Principios de Medicina Interna]]></source>
<year>2016</year>
<month>.</month>
<edition>19a</edition>
<publisher-name><![CDATA[McGraw-Hill Interamericana Editores, S.A]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saeedi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Petersohn]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Salpea]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Malanda]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Karuranga]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Unwin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.]]></article-title>
<source><![CDATA[Diabetes Research and Clinical Practice]]></source>
<year>2019</year>
<volume>157</volume>
<page-range>107843</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18.</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montier Iglesias]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cabezas Alfonso]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Cabrera]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Linares Guerra]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Jerez Hernández]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Wistar diabéticas.]]></surname>
<given-names><![CDATA[Efecto de la vitamina E sobre antioxidantes endógenos en ratas]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev. cienc. méd. Pinar Río]]></source>
<year>2018</year>
<volume>22</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>438-52</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kocak]]></surname>
<given-names><![CDATA[MZ]]></given-names>
</name>
<name>
<surname><![CDATA[Aktas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Erkus]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sincer]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Atak]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Duman]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus.]]></article-title>
<source><![CDATA[Rev. Assoc. Med. Bras]]></source>
<year>2019</year>
<volume>65</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-15.</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[YY]]></given-names>
</name>
<name>
<surname><![CDATA[Kao]]></surname>
<given-names><![CDATA[TW]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
<name>
<surname><![CDATA[Chou]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects: an observational study.]]></article-title>
<source><![CDATA[Clin Chim Acta]]></source>
<year>2018</year>
<volume>478</volume>
<page-range>68-73</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
